Condition: Cervical Squamous Cell Carcinoma · Squamous Non-small-cell Lung Cancer · Colorectal Cancer · Sponsor: Alentis Therapeutics AG
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic, pharmacodynamic, preliminary anti-tumor activity, and to determine the recommended Phase II dose (RP2D) of the ALE.P03 monotherapy in adult patients with selected squamous solid tumors.
This description comes directly from the study's public registry record.
Alentis Clinical Trial Contact · +41782304288 · patientinfo@alentis.ch
Always discuss trial participation with your own doctor first.
| Mayo Clinic Comprehensive Cancer Center | Phoenix, Arizona, United States | Recruiting |
| USC Norris Comprehensive Cancer Center | Los Angeles, California, United States | Recruiting |
| Yale Comprehensive Cancer Center | New Haven, Connecticut, United States | Recruiting |
| The University of Chicago Medical Center - Oncology | Chicago, Illinois, United States | Recruiting |
| Norton Cancer Institute - Norton Healthcare Pavilion | Louisville, Kentucky, United States | Recruiting |
| John Theurer Cancer Center | Hackensack, New Jersey, United States | Recruiting |
| MD Anderson Cancer Center | Houston, Texas, United States | Recruiting |
| Next Oncology-Oncology | San Antonio, Texas, United States | Recruiting |
| NEXT Oncology Virginia | Fairfax, Virginia, United States | Recruiting |
| Centre Georges Francois Leclerc - Oncologie Medicale | Dijon, France | Recruiting |
| CHU La Timone | Marseille, France | Recruiting |
| Centre Hospitalier Universitaire (CHU) de Toulouse - Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-Oncopole) | Toulouse, France | Recruiting |
+ 29 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07169734